Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (231-240 of 753) with videos related to

Pageof 76
Sort By:
Blood|May 23, 2001
Resting and activated endothelial cells are increased in the peripheral blood of cancer patientsP Mancuso, A Burlini, G Pruneri, et al.
Deutsche Medizinische Wochenschrift (1946)|May 3, 1985
[Polyneuropathy after cisplatin treatment]C Meier, A Goldhirsch, C Hess, et al.
Lancet (London, England)|September 12, 2000
Taxanes as adjuvant for breast cancerA Goldhirsch, P Francis, M Castiglione-Gertsch, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1984
[Intratumoral regional differences in hormone receptor status of breast cancer]G W Locher, B Davis, D T Zava, et al.
Ear, Nose, & Throat Journal|August 1, 1979
Warthin's tumor with Sjögren's syndrome and non-Hodgkin's lymphomaM Reiner, A Goldhirsch, P R Luscieti, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 1, 1984
Immunohistochemical localization of galactosyltransferase in the normal human ovary and fallopian tubeB W Davis, E G Berger, G W Locher, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2000
Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study GroupM Castiglione-Gertsch, R D Gelber, A O'Neill, et al.
Schweizerische Medizinische Wochenschrift|October 24, 1981
[Nausea and vomiting during chemotherapy of malignant tumors]R Joss, R Galeazzi, A Gervasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysisA Goldhirsch, R D Gelber, R J Simes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Pageof 76

Showing results (231-240 of 753) with videos related to

Sort By:
Pageof 76
Blood|May 23, 2001
Resting and activated endothelial cells are increased in the peripheral blood of cancer patientsP Mancuso, A Burlini, G Pruneri, et al.
Deutsche Medizinische Wochenschrift (1946)|May 3, 1985
[Polyneuropathy after cisplatin treatment]C Meier, A Goldhirsch, C Hess, et al.
Lancet (London, England)|September 12, 2000
Taxanes as adjuvant for breast cancerA Goldhirsch, P Francis, M Castiglione-Gertsch, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1984
[Intratumoral regional differences in hormone receptor status of breast cancer]G W Locher, B Davis, D T Zava, et al.
Ear, Nose, & Throat Journal|August 1, 1979
Warthin's tumor with Sjögren's syndrome and non-Hodgkin's lymphomaM Reiner, A Goldhirsch, P R Luscieti, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 1, 1984
Immunohistochemical localization of galactosyltransferase in the normal human ovary and fallopian tubeB W Davis, E G Berger, G W Locher, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2000
Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study GroupM Castiglione-Gertsch, R D Gelber, A O'Neill, et al.
Schweizerische Medizinische Wochenschrift|October 24, 1981
[Nausea and vomiting during chemotherapy of malignant tumors]R Joss, R Galeazzi, A Gervasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysisA Goldhirsch, R D Gelber, R J Simes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Pageof 76